Literature DB >> 6168890

Pharmacological effect of beta toxin of Clostridium perfringens type C on rats.

J Sakurai, Y Fujii, M Matsuura, K Endo.   

Abstract

The biological effect of purified beta toxin of Clostridium perfringens type C in vivo was investigated. After intravenous injection of the purified beta toxin into rats, a rise in blood pressure and a simultaneous fall in heart rate were observed. After the blood pressure reached a maximum, the heart rate recovered gradually, and electrocardiographic and respiratory changes began. The rise in blood pressure induced by beta toxin tended to be proportional to the amount of toxin. The latent period between the injection of toxin and the onset of the increase, and also the time between the injection and the maximum pressure induced by the toxin decreased with increasing concentration of the toxin. A good correlation was found between the factor producing the rise in blood pressure and beta toxin. Alpha adrenergic and ganglionic blocking agents reduced blood pressure levels elevated by beta toxin. The data suggest that the toxin causes a release of catecholamines, and that the increase in blood pressure was induced by released catecholamines.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168890     DOI: 10.1111/j.1348-0421.1981.tb00045.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  12 in total

Review 1.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 2.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

3.  Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers.

Authors:  O Shatursky; R Bayles; M Rogers; B H Jost; J G Songer; R K Tweten
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China.

Authors:  J Liu; H Yang; Z Yin; X Jiang; H Zhong; D Qiu; F Zhu; R Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-17       Impact factor: 3.267

5.  The p38 MAPK and JNK pathways protect host cells against Clostridium perfringens beta-toxin.

Authors:  Masahiro Nagahama; Masahiro Shibutani; Soshi Seike; Mami Yonezaki; Teruhisa Takagishi; Masataka Oda; Keiko Kobayashi; Jun Sakurai
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

6.  Effect of Clostridium perfringens epsilon toxin on the cardiovascular system of rats.

Authors:  J Sakurai; M Nagahama; Y Fujii
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

7.  Clostridium perfringens Type C Enterotoxemia.

Authors:  L Niilo
Journal:  Can Vet J       Date:  1988-08       Impact factor: 1.008

8.  Involvement of tachykinin receptors in Clostridium perfringens beta-toxin-induced plasma extravasation.

Authors:  Masahiro Nagahama; Shinsuke Morimitsu; Atsushi Kihara; Masahiko Akita; Koujun Setsu; Jun Sakurai
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

9.  Involvement of tumour necrosis factor-alpha in Clostridium perfringens beta-toxin-induced plasma extravasation in mice.

Authors:  M Nagahama; A Kihara; H Kintoh; M Oda; J Sakurai
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

10.  Clostridium Perfringens Toxins Involved in Mammalian Veterinary Diseases.

Authors:  F A Uzal; J E Vidal; B A McClane; A A Gurjar
Journal:  Open Toxinology J       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.